Follicular thyroid cancer pathophysiology: Difference between revisions
| Line 42: | Line 42: | ||
==Gross Pathology== | ==Gross Pathology== | ||
* Encapsulated tumors | * Encapsulated tumors | ||
[[ | [[File:Folladen.jpg|thumb|left|Gross pathological section of a follicular thyroid carcinoma (tumor at the bottom).]] | ||
==Microscopic Pathology== | ==Microscopic Pathology== | ||
Revision as of 15:19, 18 July 2019
|
Follicular thyroid cancer Microchapters |
|
Differentiating Follicular thyroid cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Follicular thyroid cancer pathophysiology On the Web |
|
American Roentgen Ray Society Images of Follicular thyroid cancer pathophysiology |
|
Risk calculators and risk factors for Follicular thyroid cancer pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Follicular thyroid cancer arises from follicular cells of thyroid, which are secretory cells that are normally involved in production and secretion of thyroid hormones, thyroxine (T4) and triiodothyronine (T3). Genes involved in the pathogenesis of follicular thyroid cancer include RAS, PAX8/PPARγ, and PTEN.
Pathogenesis
- Follicular thyroid cancer is the second most common type of cancer. It constitutes about 15% of thyroid cancers.
- Follicular thyroid cancer occurs more commonly in women over 50 years of age.
- Thyroglobulin (Tg) can be used as a tumor marker for well-differentiated follicular thyroid cancer.
- Follicular carcinoma tends to metastasize to the lungs and bone via the bloodstream.
- Follicular thyroid cancer metastasizes to lymph nodes late in the course of the disease, with only 5 - 10% of patients having nodal metastases at the time of diagnosis.
- Hematogenous spread is however much more common with 20% of the patients having distant hematogenous metastases at at the time of diagnosis.
- A Hürthle cell (also known as Askanazy cell) is an oncocytic cell in the thyroid that is often associated with Hashimoto's thyroiditis as well as follicular thyroid cancer.[1]
Genetics
- The Ras oncogene is positive in a significant proportion of individuals.
- The Ras oncogene acts through the RAF-MEK-MAPK kinase pathway.
- Other genes involved in the pathogenesis of follicular thyroid cancer are:
- PAX8/PPARγ (translocation) associated with PAX8-associated nuclear transcription signaling pathways. PAX8 is responsible for the follicular cell differentiation.
- Phosphatase and tensin homologue suppressor gene and the phosphatidylinositol 3-kinase pathway are also involved in the pathogenesis of follicular thyroid tumor.
- P53 (protein), c-myc, c-fos, and the thyrotropin (TSH) receptor are some other factors involved in the pathogenesis of follicular thyroid cancer.
- MicroRNAs namely miR-192, miR-197, miR-328, and miR-346 have increased expression in follicular cell carcinoma.
Associated Conditions
- Cowden disease
- Carney complex, type I
Gross Pathology
- Encapsulated tumors
Microscopic Pathology
- On microscopic examination, trabecular, solid, follicular tumor cells that invade tumor capsule or surrounding vascular structures are found.
![Metastatic follicular thyroid carcinoma[2]](/index.php/File:Metastatic_follicular_thyroid_carcinoma_-_Case_264_(8558730243).jpg)
![Metastatic follicular thyroid carcinoma[3]](/index.php/File:Metastatic_follicular_thyroid_carcinoma_-_Case_264.jpg)
Histopathological Video
Video
{{#ev:youtube|3_eCHeOkdgg}}
References
- ↑ Aytug, Serhat (June 13, 2006). "Hurthle Cell Carcinoma". eMedicine. Check date values in:
|date=(help) - ↑ http://librepathology.org/wiki/index.php/File:Metastatic_follicular_thyroid_carcinoma_-_Case_264_(8558730243).jpg Accessed on October, 29 2015
- ↑ http://librepathology.org/wiki/index.php/File:Metastatic_follicular_thyroid_carcinoma_-_Case_264_(8559837390).jpg Accessed on October, 29 2015
.jpg){kind=link}
.jpg){kind=link}